|
1
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: A delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuzuya T, Hoshida S, Yamashita N, Fuji H,
Oe H, Hori M, Kamada T and Tada M: Delayed effects of sublethal
ischemia on the acquisition of tolerance to ischemia. Circ Res.
72:1293–1299. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bolli R: The late phase of
preconditioning. Circ Res. 87:972–983. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bolli R: The early and late phases of
preconditioning against myocardial stunning and the essential role
of oxyradicals in the late phase: An overview. Basic Res Cardiol.
91:57–63. 1996.PubMed/NCBI
|
|
5
|
Rizvi A, Tang XL, Qiu Y, Xuan YT, Takano
H, Jadoon AK and Bolli R: Increased protein synthesis is necessary
for the development of late preconditioning against myocardial
stunning. Am J Physiol. 277:H874–H884. 1999.PubMed/NCBI
|
|
6
|
Hoek T Vanden, Becker LB, Shao ZH, Li CQ
and Schumacker PT: Preconditioning in cardiomyocytes protects by
attenuating oxidant stress at reperfusion. Circ Res. 86:541–548.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morihira M, Hasebe N, Baljinnyam E,
Sumitomo K, Matsusaka T, Izawa K, Fujino T, Fukuzawa J and Kikuchi
K: Ischemic preconditioning enhances scavenging activity of
reactive oxygen species and diminishes transmural difference of
infarct size. Am J Physiol Heart Circ Physiol. 290:H577–H583. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoshida S, Yamashita N, Otsu K and Hori M:
The importance of manganese superoxide dismutase in delayed
preconditioning: Involvement of reactive oxygen species and
cytokines. Cardiovasc Res. 55:495–505. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shinmura K, Bolli R, Liu SQ, Tang XL,
Kodani E, Xuan YT, Srivastava S and Bhatnagar A: Aldose reductase
is an obligatory mediator of the late phase of ischemic
preconditioning. Circ Res. 91:240–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jancsó G, Cserepes B, Gasz B, Benkó L,
Borsiczky B, Ferenc A, Kürthy M, Rácz B, Lantos J, Gál J, et al:
Expression and protective role of heme oxygenase-1 in delayed
myocardial preconditioning. Ann N Y Acad Sci. 1095:251–261. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagakubo D, Taira T, Kitaura H, Ikeda M,
Tamai K, Iguchi-Ariga SM and Ariga H: DJ-1, a novel oncogene which
transforms mouse NIH3T3 cells in cooperation with ras. Biochem
Biophys Res Commun. 231:509–513. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cremer JN, Amunts K, Schleicher A,
Palomero-Gallagher N, Piel M, Rösch F and Zilles K: Changes in the
expression of neurotransmitter receptors in Parkin and DJ-1
knockout mice-A quantitative multireceptor study. Neuroscience.
311:539–551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lev N, Ickowicz D, Barhum Y, Lev S,
Melamed E and Offen D: DJ-1 protects against dopamine toxicity. J
Neural Transm (Vienna). 116:151–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lev N, Ickowicz D, Melamed E and Offen D:
Oxidative insults induce DJ-1 upregulation and redistribution:
Implications for neuroprotection. Neurotoxicology. 29:397–405.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taira T, Saito Y, Niki T, Iguchi-Ariga SM,
Takahashi K and Ariga H: DJ-1 has a role in antioxidative stress to
prevent cell death. EMBO Rep. 5:213–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou W and Freed CR: DJ-1 up-regulates
glutathione synthesis during oxidative stress and inhibits A53T
alpha-synuclein toxicity. J Biol Chem. 280:43150–43158. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu HS, Chen HP, Wang S, Yu HH, Huang XS,
Huang QR and He M: Hypoxic preconditioning up-regulates DJ-1
protein expression in rat heart-derived H9c2 cells through the
activation of extracellular-regulated kinase 1/2 pathway. Mol Cell
Biochem. 370:231–240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Das A, Salloum FN, Durrant D, Ockaili R
and Kukreja RC: Rapamycin protects against myocardial
ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. J
Mol Cell Cardiol. 53:858–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel HH, Gross ER, Peart JN, Hsu AK and
Gross GJ: Sarcolemmal KATP channel triggers delayed ischemic
preconditioning in rats. Am J Physiol Heart Circ Physiol.
288:H445–H447. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sugano M, Hata T, Tsuchida K, Suematsu N,
Oyama J, Satoh S and Makino N: Local delivery of soluble TNF-alpha
receptor 1 gene reduces infarct size following ischemia/reperfusion
injury in rats. Mol Cell Biochem. 266:127–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera
JS, Halkos ME, Kerendi F, Guyton RA and Vinten-Johansen J:
Postconditioning attenuates myocardial ischemia-reperfusion injury
by inhibiting events in the early minutes of reperfusion.
Cardiovasc Res. 62:74–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adluri RS, Thirunavukkarasu M, Zhan L,
Dunna NR, Akita Y, Selvaraju V, Otani H, Sanchez JA, Ho YS and
Maulik N: Glutaredoxin-1 overexpression enhances neovascularization
and diminishes ventricular remodeling in chronic myocardial
infarction. PLoS One. 7:e347902012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thandavarayan RA, Giridharan VV, Arumugam
S, Suzuki K, Ko KM, Krishnamurthy P, Watanabe K and Konishi T:
Schisandrin B prevents doxorubicin induced cardiac dysfunction by
modulation of DNA damage, oxidative stress and inflammation through
inhibition of MAPK/p53 signaling. PLoS One. 10:e01192142015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Das DK and Maulik N: Cardiac genomic
response following preconditioning stimulus. Cardiovasc Res.
70:254–263. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yellon DM and Downey JM: Preconditioning
the myocardium: From cellular physiology to clinical cardiology.
Physiol Rev. 83:1113–1151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saeed SA, Waqar MA, Zubairi AJ, Bhurgri H,
Khan A, Gowani SA, Waqar SN, Choudhary MI, Jalil S, Zaidi AH and
Ara I: Myocardial ischaemia and reperfusion injury: Reactive oxygen
species and the role of neutrophil. J Coll Physicians Surg Pak.
15:507–514. 2005.PubMed/NCBI
|
|
27
|
Zweier JL and Talukder MA: The role of
oxidants and free radicals in reperfusion injury. Cardiovasc Res.
70:181–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park JL and Lucchesi BR: Mechanisms of
myocardial reperfusion injury. Ann Thorac Surg. 68:1905–1912. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dhalla NS, Elmoselhi AB, Hata T and Makino
N: Status of myocardial antioxidants in ischemia-reperfusion
injury. Cardiovasc Res. 47:446–456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rui T, Cepinskas G, Feng Q and Kvietys PR:
Delayed preconditioning in cardiac myocytes with respect to
development of a proinflammatory phenotype: Role of SOD and NOS.
Cardiovasc Res. 59:901–911. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Clements CM, McNally RS, Conti BJ, Mak TW
and Ting JP: DJ-1, a cancer- and Parkinson's disease-associated
protein, stabilizes the antioxidant transcriptional master
regulator Nrf2. Proc Natl Acad Sci USA. 103:15091–15096. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhong N and Xu J: Synergistic activation
of the human MnSOD promoter by DJ-1 and PGC-1alpha: Regulation by
SUMOylation and oxidation. Hum Mol Genet. 17:3357–3367. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yokota T, Sugawara K, Ito K, Takahashi R,
Ariga H and Mizusawa H: Down regulation of DJ-1 enhances cell death
by oxidative stress, ER stress, and proteasome inhibition. Biochem
Biophys Res Commun. 312:1342–1348. 2003. View Article : Google Scholar : PubMed/NCBI
|
